Skip to content
DISCOVER THE MOST SUITABLE TESTS FOR YOU
DISCOVER THE MOST SUITABLE TESTS FOR YOU

Venient Fx Menopause - Female

Save 40% Save 40%
Original price USD 325.20
Original price USD 325.20 - Original price USD 325.20
Original price USD 325.20
Current price USD 195.12
USD 195.12 - USD 195.12
Current price USD 195.12

Test description

Venient Fx Menopause (Female) is a disruptive, non-invasive test for menopause assessment.

It is based on a routine blood test and is powered by both proprietary machine learning and public algorithms, and provides highly accurate primary diagnostic information, including the likelihood of menopause. As a first line test, the results of the parameters included in it are useful in guiding through different diagnostic, prognostic and therapeutic options. Although the results are usually preliminary in decision making, in some cases, they can be definitive.

It is based on the determination of estradiol, follicle stimulating hormone (FSH) and luteinizing hormone (LH), as well as the FSH/LH ratio.

In case of a positive result, the diagnostic report may suggest the performance of a specific second line test, in order to deepen the diagnostic information, confirm therapies, establish prognoses or follow up the disease.

If menopause is suggested, other tests will be recommended as appropriate.

United States Preventative Services Task Force (USPSTF) diagnostic confirmation recommendations 

The United States Preventative Services Task Force (USPSTF) does not include any recommendations for menopause screening.

However, Kience Inc. recommends the Venient Fx Menopause (Female) test to treat patients with symptoms, signs or suspicion of disease: women with any symptoms or suspicion of having or developing menopause, such as anxiety, mood swings, brain fog, hot flashes and irregular periods.

Intended Use

The target population for the Venient Fx Menopause (Female) test are patients with clinically suspected: women with any symptoms suspicious of having or developing menopause, such as anxiety, mood swings, brain fog, hot flashes and irregular periods.

Sample Clinical Vignette

A 45-year-old female visits her gynecologist, complaining about irregular period cycles, feeling hot flashes with sweats throughout the day and night, disturbing her sleep, and mood swings. Serum is submitted to assess of she is developing menopause.

Required Laboratory Determinations

Serum Hormones —Estradiol, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)—.


Phone Support

8/5 Human Customer Service

ChatBot Support

24/7 ChatBot Customer Service

Locations

Patient Service Centers Near You

Test description

Venient Fx Menopause (Female) is a disruptive, non-invasive test for menopause assessment.

It is based on a routine blood test and is powered by both proprietary machine learning and public algorithms, and provides highly accurate primary diagnostic information, including the likelihood of menopause. As a first line test, the results of the parameters included in it are useful in guiding through different diagnostic, prognostic and therapeutic options. Although the results are usually preliminary in decision making, in some cases, they can be definitive.

It is based on the determination of estradiol, follicle stimulating hormone (FSH) and luteinizing hormone (LH), as well as the FSH/LH ratio.

In case of a positive result, the diagnostic report may suggest the performance of a specific second line test, in order to deepen the diagnostic information, confirm therapies, establish prognoses or follow up the disease.

If menopause is suggested, other tests will be recommended as appropriate.

United States Preventative Services Task Force (USPSTF) diagnostic confirmation recommendations 

The United States Preventative Services Task Force (USPSTF) does not include any recommendations for menopause screening.

However, Kience Inc. recommends the Venient Fx Menopause (Female) test to treat patients with symptoms, signs or suspicion of disease: women with any symptoms or suspicion of having or developing menopause, such as anxiety, mood swings, brain fog, hot flashes and irregular periods.

Intended Use

The target population for the Venient Fx Menopause (Female) test are patients with clinically suspected: women with any symptoms suspicious of having or developing menopause, such as anxiety, mood swings, brain fog, hot flashes and irregular periods.

Sample Clinical Vignette

A 45-year-old female visits her gynecologist, complaining about irregular period cycles, feeling hot flashes with sweats throughout the day and night, disturbing her sleep, and mood swings. Serum is submitted to assess of she is developing menopause.

Required Laboratory Determinations

Serum Hormones —Estradiol, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH)—.